Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
Chiara Lambona, Clemens Zwergel, Sérgio Valente, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1662-1689
Open Access | Times Cited: 14
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Recent advances in label-free imaging and quantification techniques for the study of lipid droplets in cells
Hyeonwoo Kim, Seungeun Oh, Seongsoo Lee, et al.
Current Opinion in Cell Biology (2024) Vol. 87, pp. 102342-102342
Open Access | Times Cited: 10
(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease
Lucia Longhitano, Alfio Distefano, Nicolò Musso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway
Huiqing Yuan, Hyun Sung Kim, Gye Ryeol Park, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 6
Closed Access
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbașa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access
Characteristics of different lipid droplet-mitochondrial contacts patterns during lipid droplet metabolism in T2DM-induced MASLD
Ye Xu, Yuan Zhang, Wen Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Liquiritin Ameliorates Palmitic Acid‐Induced Hepatic Steatosis in Mouse Primary Hepatocytes by Suppressing the VEGFA Signaling Pathway
Qi Zhang, Yan Wang, Xiong Qingfang, et al.
Journal of Food Biochemistry (2025) Vol. 2025, Iss. 1
Open Access
An insight on the additive impact of type 2 diabetes mellitus and nonalcoholic fatty liver disease on cardiovascular consequences
Monika Bhardwaj, Papiya Mitra Mazumder
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways
Chengan Xu, Shouhao Wang, Di Meng, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access
Regular exercise alleviates metabolic dysfunction-associated steatohepatitis through rescuing mitochondrial oxidative stress and dysfunction in liver
Baoxuan Lin, Tong Wu, Mohammad Nasb, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Recent development of mitochondrial metabolism and dysfunction in osteoarthritis
Pengchao Guo, Ahmad Alhaskawi, Safwat Adel Abdo Moqbel, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Dapansutrile Regulates Mitochondrial Oxidative Stress and Reduces Hepatic Lipid Accumulation in Diabetic Mice
Ying Wu, Jiaqiang Zhou
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 148-148
Open Access
Targeting regulation of lipid metabolism with polysaccharide of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease: A review
Wei Liu, Meng Sun, Hao Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141660-141660
Closed Access
Prioritising genetic findings for drug target identification and validation
Nikita Hukerikar, Aroon D. Hingorani, Folkert W. Asselbergs, et al.
Atherosclerosis (2024) Vol. 390, pp. 117462-117462
Open Access | Times Cited: 4
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Metabolic-Associated Fatty Liver Disease: The Influence of Oxidative Stress, Inflammation, Mitochondrial Dysfunctions, and the Role of Polyphenols
Raissa Bulaty Tauil, Paula Takano Golono, Enzo Pereira de Lima, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1354-1354
Open Access | Times Cited: 4
Nanoplastic propels diet-induced NAFL to NASH via ER-mitochondrial tether-controlled redox switch
Jie Wei, Jintao Liu, Huan Wang, et al.
Journal of Hazardous Materials (2023) Vol. 465, pp. 133142-133142
Open Access | Times Cited: 10
Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis
Longfei Dai, Renao Jiang, Zhicheng Zhan, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1
Jinyu Zhang, Hao Ouyang, Xin-Nan Gu, et al.
Free Radical Biology and Medicine (2024) Vol. 224, pp. 352-365
Closed Access | Times Cited: 2
Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‑alcoholic fatty liver disease
Tumisang Edward Maseko, Moustafa Elkalaf, Eva Peterová, et al.
International Journal of Molecular Medicine (2023) Vol. 53, Iss. 2
Open Access | Times Cited: 6
New insights of DsbA-L in the pathogenesis of metabolic diseases
Siqi Li, Jinfa Wan, Zhenyu Peng, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 12, pp. 3293-3303
Closed Access | Times Cited: 1
Establishment and characterization of cytochrome P450 1A1 CRISPR/Cas9 Knockout Bovine Foetal Hepatocyte Cell Line (BFH12)
Silvia Iori, Caterina D’Onofrio, Nihay Laham-Karam, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis
Jingqin Hu, Ze Chen, Yibing Zhou, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top